Table 1.
Demographic characteristics of study population N = 1012.
| Variables | Frequency | Percentage |
|---|---|---|
| Sex | ||
| Male | 609 | 60.2 |
| Female | 403 | 39.8 |
| Age | ||
| 18–30 | 420 | 41.5 |
| 31–49 | 424 | 41.9 |
| 50–69 | 150 | 14.8 |
| 70 and more | 18 | 1.8 |
| Occupation | ||
| HCWs | 422 | 41.7 |
| Non HCWs | 590 | 58.3 |
| Residence | ||
| Kurdistan Region of Iraq | 520 | 51.4 |
| Middle and south region of Iraq | 492 | 48.6 |
| History of infection with covid | ||
| Yes | 370 | 36.6 |
| No | 642 | 63.4 |
| Smoker | ||
| Yes | 241 | 23.8 |
| No | 771 | 76.2 |
| Vaccine type | ||
| AstraZeneca | 608 | 60.1 |
| Pfizer | 296 | 29.2 |
| Sinopharm | 108 | 10.7 |
| Symptoms after vaccination | ||
| Yes | 850 | 84 |
| No | 162 | 16 |
| Severity of symptoms N = 850 | ||
| Mild | 378 | 44.5 |
| Moderate | 333 | 39.2 |
| Sever | 139 | 16.4 |
| Duration of symptoms N = 850 | ||
| < 24 h s | 329 | 38.8 |
| 1–3 days | 463 | 54.6 |
| 4days – a week | 43 | 5.1 |
| > week | 13 | 1.5 |